Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulations with enhanced SN-38 solubility and oral absorption

Formulations with enhanced SN-38 solubility and oral absorption

US Patent 12318372 · Granted Jun 3, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions for use in treating inflammatory bowel diseases and intestinal coli2018
Compositions for use in treating inflammatory bowel diseases and intestinal coli2018
Use of aryl-quinolin derivatives as inhibitors of vasculogenic mimicry2017
Use of aryl-quinolin derivatives as inhibitors of vasculogenic mimicry2017
Anthracenedione compounds2013
Anthracenedione compounds2013
Anthracenedione compounds2010
Anthracenedione compounds2010
Naphthalenedione compounds for treating inflammation related disorders and micro2009
Naphthalenedione compounds for treating inflammation related disorders and micro2009
Methods for detecting differentially expressed genes2001
2-t-butyl-3 alkyl-5-(m-hydroxyphenyl)-1,3-oxazolidines having mydriatic effect1989